Feng Chi Biotech Corp. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 99.675 million compared to TWD 99.863 million a year ago. Operating income was TWD 18.696 million compared to TWD 17.180 million a year ago. Net income was TWD 15.649 million compared to TWD 14.912 million a year ago. Basic earnings per share was TWD 1.02 compared to TWD 0.97 a year ago.